Publication | Closed Access
Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum
146
Citations
19
References
1982
Year
Gastrointestinal PharmacologyGlycobiologyGastroenterologyAmino Acid‐peptide GlucagonPeptide SciencePeptide TherapeuticsDigestive TractAntiglucagon AntibodyGastrointestinal Peptide HormoneSecretory GranulesBioactive Enteroglucagon/oxyntomodulinGlycosylationAnimal PhysiologyBiochemistryFood DigestionGlucagon‐like ActivityEndocrinologyPharmacologyNatural SciencesPhysiologyPeptide TherapeuticCellular BiochemistryMedicine
A peptide isolated from porcine gut according to its glucagon‐like activity in liver (bioactive enteroglucagon) has been characterized immunologically, biologically and chemically: its potency relative to pancreatic glucagon in interacting with an antiglucagon antibody, hepatic glucagon‐binding sites and hepatic adenylate cyclase was ∼100%, 20% and 10%, respectively. In contrast, it is ∼20‐times more potent than glucagon in oxyntic glands, justifying the term ‘oxyntomodulin’. Chemically, it consists in the 29 amino acid‐peptide glucagon elongated at its C‐terminal end by the octapeptide Lys—Arg—Asn—Lys—Asn—Asn—Ile &—Ala; accordingly, it is called ‘glucagon‐37’
| Year | Citations | |
|---|---|---|
Page 1
Page 1